 | |
| Names | |
|---|---|
| Preferred IUPAC name 6-(2,5-Dichlorophenyl)1,3,5-triazine-2,4-diamine | |
| Other names DCPDAT, Dicloguamine, MN-1695. | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| KEGG | |
| UNII | |
| |
| |
| Properties | |
| C9H7Cl2N5 | |
| Molar mass | 256.09 g·mol−1 |
| Pharmacology | |
| A02BX16 (WHO) | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Irsogladine is aphosphodiesterase inhibitor.[1]
2,4-Dichloro-6-(2,5-dichlorophenyl)-1,3,5-triazine [61479-79-6] (1)(2)Dicyandiamide [461-58-5] (3)2,5-Dichlorobenzonitrile [21663-61-6] (4)
 | This article about anorganic compound is astub. You can help Wikipedia byadding missing information. |
 | Thispharmacology-related article is astub. You can help Wikipedia byadding missing information. |
